(Q34115862)

31 July 2017

1 reference

title

The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). (English)

1 reference

attention deficit hyperactivity disorder

31 July 2017

main subject

0 references

1 reference

Bertha K Madras

1

1 reference

31 July 2017

Gregory M Miller

series ordinal

2

1 reference

31 July 2017

Alan J Fischman

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Behavioural Brain Research

31 July 2017

published in

1 reference

31 July 2017

volume

130

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

57-63

1 reference

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

High resolution brain SPECT imaging of marijuana smokers with AD/HD.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Toward a pathophysiology of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Neurobiology of attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Genotype influences in vivo dopamine transporter availability in human striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

1 reference

7 January 2021

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Review Article Neurometrics, dynamic brain imaging and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

123Ibeta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Dopamine transporter binding in Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Human dopamine transporter gene polymorphism (VNTR) and alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Genotypic association between dopamine transporter gene polymorphisms and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Dopamine transporter gene polymorphisms are not associated with polysubstance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Anti-hyperactivity medication: methylphenidate and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Attention-deficit/hyperactivity disorder and comorbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Novelty seeking and a dopamine transporter gene polymorphism (DAT1)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

The dopamine receptor DRD4 gene: are duplications distracting?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Cocaine uptake is decreased in the brain of detoxified cocaine abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

Brain metabolism in teenagers with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900439-9

7 January 2021

10.1016/S0166-4328(01)00439-9

Identifiers

DOI

1 reference

31 July 2017

1 reference